San Diego-area biotech startup Solstice Biologics has raised $18m in Series A financing led by venBio, with participation from Aeris Capital AG. The company focuses on solving the problem of targeting and delivering nucleic acid therapeutics, The company has developed a portion of its IP internally, as well as acquired portions from the University of California, San Diego. [Source: FinSMEs]